Article info

Download PDFPDF

JAK selectivity for inflammatory bowel disease treatment: does it clinically matter?

Authors

  • Silvio Danese IBD Centre, Humanitas Clinical Research Centre, Rozzano, Milan, Italy Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy PubMed articlesGoogle scholar articles
  • Marjorie Argollo Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy Gastroenterology, Universidade Federal de São Paulo, São Paulo, Brazil PubMed articlesGoogle scholar articles
  • Catherine Le Berre Gastroenterology, Nancy-Universite, Nancy, Lorraine, France PubMed articlesGoogle scholar articles
  • Laurent Peyrin-Biroulet Inserm U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy-Brabois, Vandoeuvre-lès-Nancy, France Université Henri Poincaré 1, Vandoeuvre-lès-Nancy, France PubMed articlesGoogle scholar articles
  1. Correspondence to Prof Silvio Danese, Istituto Clinico Humanitas, Rozzano 20089, Italy; sdanese{at}hotmail.com
View Full Text

Citation

Danese S, Argollo M, Le Berre C, et al
JAK selectivity for inflammatory bowel disease treatment: does it clinically matter?

Publication history

  • Received April 2, 2019
  • Revised May 10, 2019
  • Accepted May 20, 2019
  • First published June 21, 2019.
Online issue publication 
September 06, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.